更多内容请点击

中国全科医学 ›› 2016, Vol. 19 ›› Issue (27): 3317-3321.DOI: 10.3969/j.issn.1007-9572.2016.27.012

• • 上一篇    下一篇

启膈散对食管癌细胞间同质黏附力的影响

史会娟，高静，石冬璇，等   

  1. 050011 河北省石家庄市，河北医科大学第四医院中医科（史会娟，高静，李晶）；河北医科大学研究生学院（石冬璇） 通信作者：李晶，050011 河北省石家庄市，河北医科大学第四医院中医科；E-mail：lijingtiger@163.com
  • 出版日期:2016-09-20 发布日期:2026-01-15
  • 基金资助:
    国家自然科学基金资助项目（81403310）；河北省科技厅资助项目（13277718D）

Effect of Qigesan on the Cell-cell Adhesion of Esophageal Cancer

SHI H J,GAO J,SHI D X,et al   

  1. Department of Traditional Chinese Medicine,the Fourth Hospital of Hebei Medical University,Shijiazhuang 050011,China Corresponding author:LI Jing,Department of Traditional Chinese Medicine,the Fourth Hospital of Hebei Medical University,Shijiazhuang 050011,China;E-mail:lijingtiger@163.com
  • Published:2016-09-20 Online:2026-01-15

PDF
分享到

摘要： 背景　食管癌的发病率有明显的地理特征，每年约有50%的新诊断病例发生在中国。目的　研究启膈散对食管癌细胞间同质黏附力的影响，并探讨其作用机制。方法　2015年3—6月，体外培养Eca109、TE13、TE1，采用机械法检测不同剂量启膈散（0、50、100 μg/ml）（分别为对照组、低剂量组、高剂量组）干预后Eca109、TE13、TE1同质黏附值，Western blotting法检测不同剂量启膈散（0、50、100 μg/ml）（分别为对照组、低剂量组、高剂量组）干预后Eca109、TE13、TE1中Cx32表达水平，免疫细胞化学法检测不同剂量启膈散（0 μg/ml和100 μg/ml）（分别为对照组、启膈散组）干预后Eca109、TE13、TE1中E-cadherin表达情况，划痕实验检测不同剂量启膈散（0、50、100 μg/ml）（分别为对照组、低剂量组、高剂量组）干预后Eca109、TE13、TE1迁移能力。结果　低剂量组、高剂量组Eca109、TE13、TE1同质黏附值大于对照组（P<0.05）；高剂量组Eca109、TE13、TE1同质黏附值大于低剂量组（P<0.05）。低剂量组TE1中Cx32表达水平高于对照组（P<0.05）；高剂量组Eca109、TE13、TE1中Cx32表达水平高于对照组、低剂量组（P<0.05）。对照组、启膈散组Eca109、TE1、TE13中E-cadherin表达均为阴性，未见表达增强。低剂量组、高剂量组12 h、24 h时Eca109、TE13、TE1划痕宽度大于对照组（P<0.05）；高剂量组12 h时Eca109划痕宽度大于低剂量组，12 h、24 h时TE13、TE1划痕宽度大于低剂量组（P<0.05）。结论　启膈散能够增加Cx32表达水平，从而提高食管癌细胞间同质黏附力，进而抑制食管癌细胞的迁移。

关键词: 食管肿瘤, 细胞黏附, 细胞运动, 启膈散

Abstract: Background　The incidence of esophageal cancer has distinct geographical characteristics,with approximately 50% of all newly diagnosed cases occurring in China annually.Objective　To investigate the effects and mechanism of Qigesan on the cell-cell adhesion of esophageal carcinoma.Methods　From March to June in 2015,the human esophageal carcinoma cell lines Eca109,TE13 and TE1 were cultured in vitro.Eca109,TE13 and TE1 were treated with the different dose of Qigesan （0 μg/ml in control group,50 μg/ml in low dose group,100 μg/ml in high dose group）,the cell-cell adhesion was tested by mechanical method,the expression level of Cx32 in Eca109,TE13 and TE1 was detected by Western blotting method.The expression of E-cadherin in Eca109,TE13 and TE1 with different dose of Qigesan （0 μg/ml in control group,100 μg/ml in Qigesan group） was detected by SP immunohistochemistry method.The metastatic abilities of Eca109,TE13 and TE1 with different dose of Qigesan （0 μg/ml in control group,50 μg/ml in low dose group,100 μg/ml in high dose group） were detected by scratch-wound assays.Results　The cell-cell adhesion of Eca109,TE13 and TE1 in low dose group and high dose group was higher than that in control group respectively （P<0.05）;the cell-cell adhesion of Eca109,TE13 and TE1 in high dose group was higher than that in low dose group （P<0.05）.The expression level of Cx32 of TE1 in low dose group was higher than that in control group （P<0.05）;the expression level of Cx32 of Eca109,TE13 and TE1 in high dose group was higher than that in control group and low dose group respectively （P<0.05）.The expression of the E-cadherin was negative in control group and Qigesan group.At 12 h and 24 h,the scratch of Eca109,TE13 and TE1 in low dose group and high dose group was wider than that in control group respectively （P<0.05）.At 12 h,the scratch of Eca109 in high dose group was wider than that in low dose group （P<0.05）.At 12 h and 24 h,the scratch of TE13 and TE1 in high dose group was wider than that in low dose group （P<0.05）.Conclusion　Qigesan can improve the expression level of Cx32,then improve the cell-cell adhesive ability and reduce the migratory ability of esophageal carcinoma cells.

Key words: Esophageal neoplasms, Cell adhesion, Cell movement, Qigesan

冀ICP备12018774号-6　冀公网安备 13040302001295号　网站版权 © 《中国全科医学》编辑部　技术支持：北京玛格泰克科技发展有限公司